CSL-040

N/A

Report date: 2025/04/02 10:22:07

Base Information

Drug NameCSL-040
Drug Alias NameCSL-040
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement receptor type 1 antagonists
TargetsComplement receptor type 1
Therapy Area/IndicationsSoft Tissue InjuriesInflammationReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCsl Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring AgCsl Ltd
Inactive CompaniesN/A
Active IndicationsSoft Tissue InjuriesInflammationReperfusion Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A